Anbio Biotechnology (NNNN)
7.72
-0.11
(-1.40%)
USD |
NASDAQ |
Aug 26, 16:00
7.57
-0.15
(-1.94%)
Pre-Market: 20:00
Anbio Biotechnology Market Cap : 338.84M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 26, 2026 | 338.84M |
| August 25, 2026 | 343.67M |
| August 24, 2026 | 346.74M |
| August 21, 2026 | 298.90M |
| August 20, 2026 | 321.72M |
| August 19, 2026 | 340.16M |
| August 18, 2026 | 366.49M |
| August 17, 2026 | 372.42M |
| August 14, 2026 | 383.61M |
| August 13, 2026 | 450.32M |
| August 12, 2026 | 434.08M |
| August 11, 2026 | 454.27M |
| August 10, 2026 | 447.25M |
| August 07, 2026 | 465.69M |
| August 06, 2026 | 427.94M |
| August 05, 2026 | 445.50M |
| August 04, 2026 | 445.50M |
| August 03, 2026 | 467.44M |
| July 31, 2026 | 434.52M |
| July 30, 2026 | 471.83M |
| July 29, 2026 | 508.70M |
| July 28, 2026 | 445.50M |
| July 27, 2026 | 446.81M |
| July 24, 2026 | 434.52M |
| July 23, 2026 | 427.50M |
| Date | Value |
|---|---|
| July 22, 2026 | 414.77M |
| July 21, 2026 | 417.84M |
| July 20, 2026 | 417.84M |
| July 17, 2026 | 416.53M |
| July 16, 2026 | 421.36M |
| July 15, 2026 | 400.29M |
| July 14, 2026 | 417.41M |
| July 13, 2026 | 437.60M |
| July 10, 2026 | 412.14M |
| July 09, 2026 | 489.39M |
| July 08, 2026 | 504.31M |
| July 07, 2026 | 513.53M |
| July 06, 2026 | 528.45M |
| July 02, 2026 | 557.42M |
| July 01, 2026 | 541.84M |
| June 30, 2026 | 601.75M |
| June 29, 2026 | 594.73M |
| June 26, 2026 | 637.74M |
| June 25, 2026 | 706.65M |
| June 24, 2026 | 669.34M |
| June 23, 2026 | 689.09M |
| June 22, 2026 | 722.89M |
| June 18, 2026 | 730.35M |
| June 17, 2026 | 696.11M |
| June 16, 2026 | 708.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CureVac NV | 1.049B |
| PAION AG | 0.4994M |
| Epigenomics AG | 1.000M |
| ACADIA Pharmaceuticals, Inc. | 5.092B |
| Alkermes Plc | 8.236B |
Market Cap Related Metrics
| PS Ratio | 34.77 |
| PEG Ratio | 0.256 |
| Price | 7.72 |
| Earnings Yield | 2.12% |
| PEGY Ratio | 0.256 |
| Operating PE Ratio | 52.31 |
| Normalized PE Ratio | 46.34 |